| Microorganism |
|
|
|
| Antimicrobial |
 |
|
Reference |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.015 |
0.03 |
≤0.008 － 0.03 |
AC98-6446 |
175 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.03 |
0.06 |
≤0.015 － 0.25 |
Dalbavancin |
72 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.06 |
0.5 |
? － ? |
Clinafloxacin (PD 127391) |
307 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.12 |
4 |
0.03 － 8 |
Garenoxacin (T-3811, BMS-284756) |
102 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
>0.12 |
>8 |
0.06 － >8 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
73 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.12 |
8 |
0.06 － 16 |
Sparfloxacin (AT-4140, Zagam) |
117 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.12 |
32 |
≤0.12 － 64 |
Gentamicin (Gentamycin, Garamycin) |
89 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.125 |
0.5 |
0.125 － 1 |
Quinupristin/Dalfopristin (Synercid) |
72 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.125 |
0.5 |
0.125 － 1 |
Quinupristin/Dalfopristin (Synercid) |
207 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.125 |
2 |
0.125 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
1464 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
0.25 |
0.03 － 1 |
Daptomycin + 75 μg/ml Ca++ |
67 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
0.25 |
0.12 － 0.5 |
Telavancin (TD-6424, Vibativ) |
73 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
0.5 |
0.03 － 8 |
DC-159a |
268 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
0.5 |
≤0.06 － 2 |
TAK-599 |
162 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
0.5 |
≤0.063 － 2 |
Quinupristin/Dalfopristin (Synercid) |
109 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
0.5 |
0.12 － 0.5 |
Daptomycin (Cubicin) |
16 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
0.5 |
≤0.12 － >4 |
Quinupristin/Dalfopristin (Synercid) |
73 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
1 |
≤0.06 － 4 |
Ranbezolid (RBX 7644) |
72 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
1 |
≤0.06 － 4 |
Ranbezolid (RBX 7644) |
162 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
1 |
≤0.06 － 4 |
Ranbezolid (RBX 7644) |
207 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
1 |
0.125 － 2 |
Panduratin A |
1464 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
2 |
≤0.063 － 2 |
ME1036 |
109 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
2 |
0.125 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
1464 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
4 |
0.06 － 32 |
Moxifloxacin (BAY 12-8039, Avelox) |
102 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
4 |
0.12 － >32 |
Gatifloxacin (Tequin) |
102 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
4 |
0.25 － 8 |
Levofloxacin (Levaquin, Quixin) |
1464 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
8 |
0.12 － 32 |
Levofloxacin (Levaquin, Quixin) |
117 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
>0.25 |
>8 |
0.25 － >8 |
Levofloxacin (Levaquin, Quixin) |
175 |